Automated Point-of-Care CAR T-Cell Fabrication & Democratization
MIDI’s latest White Paper describing advancements their team engineered in the biopharma fabrication space: Automated Point-of-Care CAR T-Cell Fabrication & Democratization . In particular it reveals a shift from centralized to point-of-care manufacturing and how closed system automation plays a pivotal role in making this revolutionary therapy accessible to all.
Related Reading
News / Health Access / Regulatory Affairs / Small Business
Emanate Receives FDA 510(k) Clearance for Perio PODS™, the First FDA-Cleared At-Home Periodontal Wound Dressing Indicated Following Non-Surgical Periodontal Procedures
September 18, 2026
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) — Emanate Biomedical, Inc., a medical technology company creating a new category of clinician-directed at-home oral care, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for Perio PODS™, a periodontal wound dressing consisting of single-use, patient-matched dental trays preloaded with engineered hydrogel.
Blog / Artificial Intelligence (AI) / Digital Health / The MedTech Conference
AdvaMed® in Action: A New Chapter for Digital Health Tech at #MTC26
September 15, 2026
Kirsten Tullia shares how AdvaMed Digital Health Tech priorities—from AI and cybersecurity to payment and data—will come to life at #MTC26 in Boston.
Health Access
Patient Access to Breakthrough Medical Devices
Patients should not have to wait years for Medicare coverage of procedures using breakthrough medical technologies the FDA has already authorized for marketing after determining they meet applicable safety and effectiveness standards.
Event / Digital Health / Regulatory Affairs
Shifting Customer Engagement Models in Diagnostics: Winning in a Rapidly Evolving Market
September 29, 2026
2:00 PM – 3:00 PM
Join Deloitte in this discussion examining how rising consumer expectations, new technology entrants, and evolving provider roles are reshaping how diagnostics manufacturers engage their customers.
Event / Digital Health / Regulatory Affairs
Reimagining the Cost of Quality: The Agentic AI Opportunity for MedTech
September 30, 2026 10:00AM – 11:00AM ET
Join HCLTech in this discussion about practical use cases and strategies to scale AI-driven quality operations while maintaining compliance and enabling greater innovation.
News / Coverage & Payment / Health Access / Regulatory Affairs
AdvaMed Welcomes Expiration of Moratorium on New Medicare Durable Medical Equipment Suppliers
August 27, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, today welcomed the expiration of the moratorium on Medicare acceptance of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers. He made the following comment on the expiration.
Blog / Artificial Intelligence (AI) / Digital Health / Health Access
The Insight Series: AI & Digital Health with Kelly Huang
August 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. This edition features Kelly Huang, CEO of Elucid, an AI medical technology company focused on providing physicians with a more precise, non-invasive view of atherosclerosis to drive patient-specific cardiovascular care.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Statement on the Nomination of Dr. Heidi Overton as FDA Commissioner
August 19, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner.